Vaccine Weekly articles from November 2002

Vaccine Weekly archives from November 2002

Salmonella enterica Typhi vaccine protects against H. pylori infection.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Protection against Helicobacter pylori was provided by a vaccination regimen that combined a primary intranasal inoculation with a strain of...

Trypanosoma cruzi proteinase protects against trypanosomiasis.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - The major proteinase of Trypanosoma cruzi, cruzipain, showed promise as a vaccine component to prevent trypanosomiasis, according to a report in...

HHS announces contracts for developing new vaccine.(U.S. Department of Health and Human Services)
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- U.S. Department of Health and Human Services (HHS) Secretary Tommy G. Thompson has announced that the National Institute of Allergy and Infectious Diseases (NIAID) has awarded two companies contracts...

Italian vaccination surveillance system improves reporting of infections.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - A sentinel surveillance network set up in Italy to monitor vaccine-preventable infections, such as measles and mumps, was more effective at...

Contact with children who may have chickenpox confers protection against shingles to adults.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Exposure to varicella-zoster virus by frequent contact with children appears to protect adults against herpes-zoster outbreaks, according to a report...

HPV16 antibodies cause regression of cervical neoplasia.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Neutralizing antibodies against human papillomavirus 16 (HPV16) appear to cause regression of cervical intraepithelial (CIN) lesions and may even...

Autologous immunotherapy shown safe, effective.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- A clinical trial by researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) has shown a new autologous immunotherapy appears to be safe and effective treatment for controlling HIV....

Vaccine may be effective with modifications.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Trials of a promising new therapy for Alzheimer disease were abruptly halted this year when several of the more than 360 patients enrolled developed inflammation in the brain. But two new studies...

Franek Technologies advances bioterrorism preparedness.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- The nation is better prepared to deal with the public health threat of biological terrorism due to the efforts of Franek Technologies, Inc., the leader in Category III-3 Laboratory Protection Systems...

Genomic assay developer adds two independent directors to board.(Brief Article)
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- GeneThera, Inc., (GTHA) a genomics biotech company focused on the detection of infectious diseases, announced the addition of two new members to its board of directors. Loretta Zapp and John T....

Development of oral biological defense vaccines initiated.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- DOR BioPharma, Inc., (DOR) announced that it has initiated a program to produce orally administered vaccines to protect against exposure to biological agents that can potentially be used in bioterrorist...

FDA streamlining of biopharmaceutical review a welcomed development.(Brief Article)
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- In response to the FDA's plan to consolidate reviews of pharmaceutical products, including biologics, at the Center for Drug Evaluation and Research, BIO [Biotechnology Industry Organization] president...

Investigational new drug applications filed for M-Vax, O-Vax.(Brief Article)
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Avax Technologies, Inc., (AVXT) announced the submission of investigational new drug applications (IND) for M-Vax and O-Vax, its AC Vaccine technology product candidates for the treatment of melanoma...

Hepatitis A vaccine protects hemodialysis patients from viral infection.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Hepatitis A vaccine is a feasible way to protect end-stage kidney disease patients from infection, according to a new study. Reporting in the journal...

$4.5M raised in self-underwritten public offering by BioSante.(Brief Article)
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BISP) announced that it has raised $4,500,000 in a self-underwritten, best efforts public offering under a registration statement filed with the Securities and Exchange...

NIH intended for development of oral prophylactic/therapeutic HIV vaccine.(National Institutes of Health)
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- BioDelivery Sciences International (BDSI; BDSIW) announced that they have received a 2-year $600,000 National Institutes of Health (NIH) SBIR Grant to develop an oral form of a powerful HIV...

Efficacy trials will assess prophylactic and therapeutic indications.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Antex Biologics, Inc. (ANX) has announced that two phase II trials for its Helivax vaccine against Helicobacter pylori are scheduled to begin next quarter. One trial will assess the preventative...

Medicare rule change sets new standards.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- A U.S. rule revision will help facilitate delivery of influenza and pneumococcal vaccinations in hospitals, home health agencies, and nursing homes serving Medicare or Medicaid patients. The...

FDA approves preservative-free flu vaccine for pediatric use.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Aventis Pasteur announced the U.S. Food and Drug Administration (FDA) has approved licensure to market Fluzone Preservative-free: Pediatric Dose, Influenza Virus Vaccine. For the first time,...

Vaccine shipments should arrive in time for high-risk patients.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Aventis Pasteur, the largest U.S. supplier of influenza vaccine, planned to complete shipping partial orders of Fluzone, influenza virus vaccine, to all of its customers by the end of September, with...

Parasite, mosquito genomes complete malaria picture.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Genome sequences of Plasmodium falciparum, the most lethal malaria-causing parasite, and Anopheles gambiae, a mosquito that transmits the parasite to humans, are now complete, two international research...

Fears of an epidemic prompt urgent vaccination campaign in famine-hit Zimbabwe.(Brief Article)
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Fears of a measles epidemic prompts urgent vaccination campaign in famine-hit Zimbabwe With an estimated 3 million Zimbabwean children at risk because of drought and food shortages, fears of a...

Researchers identify candidate vaccine.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- Researchers at the Hospital for Sick Children (HSC), Toronto Western Hospital and the University of Toronto (U of T) have identified the protein that triggers the autoimmune response in Sjogren...

Pediatricians urge vaccine limits.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- The American Academy of Pediatrics says the nation's smallpox plan should involve limited vaccinations if a case occurs, not universal inoculations before there's even an attack. Potential side...

U.S. divided on vaccination policy.
November 6, 2002... 2002 NOV 6 - (NewsRx.com & NewsRx.net) -- The Bush administration plans to offer the smallpox vaccine to the general public, but officials weighing the risk of the vaccine against the risk of bioterrorism remain divided over how quickly to act....

Vaccine effective against melanoma in mice.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Immunization with a vaccine containing mouse fibroblasts transfected with DNA from B16 mouse melanoma cells that expressed syngeneic and allogeneic...

Dendritic cells expressing tumor antigen, GM-CSF elicit potent tumor-specific immune response.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Cotransduction of granulocyte macrophage colony-stimulating factor (GM-CSF) into dendritic cells (DCs) already capable of expressing specific tumor...

Novel mucosal adjuvant safe, effective.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Japan and the United States have developed a chimeric protein that may offer protection from a number of bacterial toxins. Mi-Na Kweon and...

Close monitoring important to reduce risk from large-scale vaccination.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- In a commentary in the Journal of the American Medical Association, smallpox experts outline the potential risks associated with large-scale vaccination against the smallpox virus. The authors...

Tetanus booster increases serum, but not saliva, antibody levels.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - A subcutaneous booster injection of tetanus toxoid increased levels of tetanus toxoid-specific antibodies in serum but not in saliva, according to...

DTaP vaccine rarely causes serious injection site reactions.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - A 4-year survey of medically attended injection site reactions (ISR) from the diphtheria-tetanus toxoid-acellular pertussis (DTaP) vaccine revealed...

Vaccine maker initiates cost reduction program.(Biomira, Inc.)
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM) (TSX:BRA) announced that the company has initiated a cost reduction program focused primarily on curtailing earlier research programs in favor of continuing development of its two...

Enrollment completed for phase II pilot study of vaccine for metastatic disease.(Brief Article)
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM) (TSX: BRA) announced that the company has completed enrolment of its phase II pilot study of Theratope vaccine for metastatic colorectal cancer. The 20-patient study was...

Monoclonal antibody production agreement signed.(Brief Article)
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- Dutch antibody and vaccine company Crucell N.V. (Euronext, Nasdaq: CRXL) and San Diego, California-based Applied Molecular Evolution, Inc., (AME) (AMEV) announced that they have signed a nonexclusive,...

Japanese patent covering SAGE technology granted.(Serial Analysis of Gene Expression)
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- Genzyme Molecular Oncology (GZMO) announced that the Japanese Patent Office has issued Patent No. 3334806 covering its powerful SAGE technology. The patent covers the methodology by which SAGE...

Therapeutic vaccine's safety shown in clinical evaluation.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- A clinical team in Mexico evaluating the AuRx therapeutic vaccine for genital herpes has published the initial results of a safety evaluation for the lowest dose in a phase I/II trial for treatment of...

Phase II vaccine efficacy trials set to begin.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- Antex Biologics, Inc., (AMEX:ANX) announced that two phase II trials for its Helivax vaccine against Helicobacter pylori, a bacterial pathogen responsible for peptic ulcers and stomach cancers, are...

Fellowship funds study of dendritic cell role in immune response.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- The American Foundation for AIDS Research (amfAR) has awarded Emory microbiologist Sang-Moo Kang, PhD, a fellowship to study how dendritic cells might be used to improve the immune response against...

Interaction of novel DNA structures and immune system activation studied.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- Hybridon, Inc., (HYBN.OB) announced the publication of two articles presenting the results of murine cell culture experiments conducted by Hybridon involving the relationships between novel DNA...

Experts recommend that asthmatics get flu shot.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- People with asthma should get a flu shot this fall to help prevent asthma attacks during flu season, the American Lung Association (ALA) recommends. Although the flu poses a major health risk to...

FluINsure vaccine results presented at ICAAC.(Interscience Conference on Antimicrobial Agents and Chemotherapy)
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- ID Biomedical announced that Dr. Scott Halperin of the Clinical Trials Research Center at IWK Health Center and Dalhousie University in Halifax, Nova Scotia, presented phase I clinical trial results...

Survey shows demand high for needle-free, intranasal flu vaccine.(Brief Article)
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- According to a survey conducted by SG Cowen, there is strong demand among doctors for FluMist, a flu vaccine that is administered through the nose rather than by a shot in the arm. The survey also...

Vaccination against and treatment for influenza appear to be cost-effective.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - A cost-benefit analysis conducted by a team at Duke University concluded vaccination against influenza and antiviral treatments for influenza-like...

Epimmune awarded NIH vaccine contract.(National Institutes of Health)(Brief Article)
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN), a biotechnology company focused on the development of pharmaceutical products using multiple, specific epitopes to activate the body's immune system, announced that it has been...

Collaboration announced for experimental vaccine.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) announced the initiation of a collaborative agreement with Leland Stanford Junior University (Stanford) for an immunotherapeutic vaccine clinical study for multiple...

Positive results reported for vaccine against potential bioterror agent.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- ID Biomedical announced encouraging results from preclinical studies of its nasally delivered proteosome-based plague pneumonia vaccine. Mice immunized nasally with the proteosome-based plague...

Cancer immunotherapy company chooses new communications firm.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- Genitope Corp. has selected Dorland Global Health Communications as its agency of record, Dorland announced. Genitope Corp. is a biotechnology company that focuses on discovering and developing...

Federal officials debate whether to recommend, or simply offer vaccine.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- It's one thing to offer a risky, possibly deadly, smallpox vaccine. It's another to urge people to take it. U.S. officials planning for smallpox vaccinations are still debating this key issue:...

Feds to monitor vaccine.(Brief Article)
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- Stuck with 30-year-old data about the effects of the smallpox vaccine, federal officials have created a comprehensive system to track and monitor those who may receive the shots. The system would...

Florida health care workers learn how to vaccinate population.
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- A group of Florida public health care workers armed with two-pronged needles trained to give smallpox vaccinations as part of a nationwide strategy to prepare for a potential bioterror attack. The...

E.U. project on killer bacteria may lead to vaccine development.(European Union)
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- Serious Streptococcus infections is the theme of a major E.U. project to be coordinated and led by researchers from Lund University, Sweden. Associate Professor Claes Schalen and researcher Aftab...

Dow obtains patents for production of glycoproteins in plant systems.(Brief Article)
November 13, 2002... 2002 NOV 13 - (NewsRx.com & NewsRx.net) -- The Dow Chemical Company (NYSE:DOW) has acquired a global, exclusive assignment of patents involving significant technology in protein glycosylation for enabling the production of "mammalian-like"...

Stromal cell-derived factor 1 effective against leukemia and melanoma in murine models.
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Vaccination with irradiated tumor cells expressing stromal cell-derived factor 1 (SDF-1) prevented tumor growth in tumor cell-challenged naive mice...

Rotavirus vaccine could protect children from infection and related diarrhea.
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Data gathered on infants in Guinea-Bissau, West Africa, indicated that a rotavirus vaccine could provide protection against rotavirus-related...

More resources needed to vaccinate 95% of all children.
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- The struggle to vaccinate as many children as possible in the Americas has been one of the priorities of the Pan American Health Organization (PAHO) since its creation. This huge effort has...

Review article covers details involved in developing effective influenza vaccines.
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - The effectiveness of an influenza vaccine prior to the season is difficult to predict because of uncertainty about circulating virus levels, vaccine...

Meningococcal C conjugate vaccine safe and effective.
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Infants who received meningococcal C conjugate (Men C) vaccinations possessed high antibody levels at the age of 4 years, according to a report in...

Study shows why some immune systems control HIV.
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- Scientists are beginning to change their thinking about why the immune systems of most people infected with HIV cannot control the spread of the virus while the immune systems of a rare group of...

Industry executive named to vaccine developer's board.
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- ID Biomedical announced the appointment of Michel Greco to its board of directors. Greco has had a long career in the pharmaceutical and vaccine industry. In 1998, he was appointed president and...

Avax Technologies signs distribution agreement.(Brief Article)
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- Avax Technologies, Inc., (NASDAQ:AVXT) announced it signed a Distribution Agreement with Ferrer Internacional, S.A. (Grupo Ferrer) for sales and distribution of the AC Vaccine Technology in Europe,...

Clinical trials for melanoma and ovarian cancer receive go-ahead.
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- Avax Technologies, Inc., (NASDAQ:AVXT) announced that the U.S. Food and Drug Administration (FDA) has confirmed that there are no outstanding issues with regard to the company's investigational new...

Company's third quarter revenue positively affected by HIV, HCV contracts.(Brief Article)
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- Boston Biomedica, Inc., (NASDAQ:BBII) reported its third quarter financial results. "Third quarter revenue increased 8.6%, driven primarily by strong activity in two service contracts related to...

Novel DNA molecules are potent, selective immunoregulators.
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- Hybridon, Inc., (HYBN) announced that its researchers have published data on novel DNA molecules that stimulate the immune system with increased potency and selectivity. These molecules, which use...

FluINsure vaccine challenge study in U.K. is approved.
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- ID Biomedical announced that it has received a favorable response from the Medicines Control Agency of the United Kingdom with regard to its application to conduct a phase II human "challenge" study...

Vaccination fails to protect French workers from the flu.
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - The 1996-1997 influenza vaccine (A/Wuhan/359/95 strain) was ineffective at protecting workers in France, according to a report in Occupational...

CytRx Corp. announces agreement with Sands Brothers.
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- CytRx Corp. (NASDAQ:CYTR) announced its board of directors has approved the hiring of Sands Brothers & Company, Ltd., through an Investment Banking Agreement focusing on potential strategic alliances,...

Full commercial rights to GVAX vaccines reacquired.
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- Cell Genesys, Inc., (NASDAQ:CEGE) announced that it has reacquired full commercial rights to GVAX lung cancer vaccines following the termination of its remaining license agreement with the...

Reproducible primate malaria transmission model developed by Colombian researchers.
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - A research team at the University of Valle in Cali, Colombia, has developed a reproducible nonhuman primate model of malaria transmission using Aotus...

No serious adverse interactions found MCC vaccines and diphtheria-tetanus booster.(meningococcal C conjugate)
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - The timing of immunization with a meningococcal C conjugate (MCC) conjugated to a tetanus or diphtheria toxoid relative to the administration of a...

New hope for vaccine to fight RA, other autoimmune disorders.(rheumatoid arthritis)
November 20, 2002... 2002 NOV 20 - (NewsRx.com & NewsRx.net) -- Promising animal test results that could lead to a vaccine to fight rheumatoid arthritis, multiple sclerosis (MS) and other autoimmune diseases were announced by researchers at the Technion-Israel...

Vaccine protects against aspergillosis.
November 27, 2002... 2002 NOV 27 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - A vaccine containing a sonicated preparation of Aspergillus fumigatus protected mice against invasive pulmonary aspergillosis, according to a...

Method to transduce leukemia B cells developed.
November 27, 2002... 2002 NOV 27 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - A research team from Ludwig-Maximilians-University in Munich have developed a method to transduce B cells of chronic lymphocytic leukemia using...

Postexposure hepatitis B vaccine not effective in hemodialysis patients.
November 27, 2002... 2002 NOV 27 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Accelerated hepatitis B vaccine schedules are not very effective for protecting hemodialysis patients after they have been exposed to hepatitis B virus (HBV)....

Vaccine blunts virus's sting.(hepatitis C virus)
November 27, 2002... 2002 NOV 27 - (NewsRx.com & NewsRx.net) -- The livers of people infected with hepatitis C could be saved if one of a handful of experimental vaccines lives up to its early promise. Innogenetics of Belgium has reported that its therapeutic...

RNA interference research valuable for studying malaria parasite gene expression.
November 27, 2002... 2002 NOV 27 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Results from RNA interference studies indicated that blocking the expression of two cysteine protease genes in the malaria parasite Plasmodium...

Report looks at genomic, proteomic, bioinformatic advances.(Brief Article)
November 27, 2002... 2002 NOV 27 - (NewsRx.com & NewsRx.net) -- Jain PharmaBiotech announced the publication of a report entitled "Animal Biotechnology: Technologies, Companies and Markets." The report includes veterinary biotechnology, where the applications...

Phase I vaccine clinical trial begins.(Brief Article)
November 27, 2002... 2002 NOV 27 - (NewsRx.com & NewsRx.net) -- DynPort Vaccine Company LLC (DVC), which focuses on biodefense vaccines, announced that it will enter into a phase I clinical trial consisting of approximately 70 volunteers for a new, injectable...

Metastatic breast cancer vaccine trial to continue.(Brief Article)
November 27, 2002... 2002 NOV 27 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM), of Edmonton, Alberta, Canada, and Merck KGaA of Darmstadt, Germany, announced that they will continue their phase III clinical trial of Theratope vaccine through its planned...

Regulatory T cells may have a role in poor immune response against tumor antigens.
November 27, 2002... 2002 NOV 27 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - The weak immunogenicity of tumor antigens may be due to regulatory T cells that suppress the response of self-reactive T cells to prevent development...

Software keeps track of vaccination records.(eImmune from I-trax, Inc.)
November 27, 2002... 2002 NOV 27 - (NewsRx.com & NewsRx.net) -- I-trax, Inc. (IMTX) , a population health-management solutions company, announced that it has deployed the latest version of eImmune software solution at key locations in the National Capitol Region of...

Biotech company says its scientists have created new molecules.
November 27, 2002... 2002 NOV 27 - (NewsRx.com & NewsRx.net) -- Maxygen, Inc., (MAXY) announced that its scientists have created a series of molecules that could be used to treat a variety of diseases including cancer, infectious diseases, and autoimmune diseases....

Study: CAP nanoparticles induce immunity and protection from herpes.(calcium phosphate)
November 27, 2002... 2002 NOV 27 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BISP) announced results of a study that found its patented calcium phosphate nanoparticles (CAP) vaccine adjuvant to be an effective mucosal adjuvant capable of...

Officials look to limit lawsuits extending from vaccine.(smallpox vaccine)
November 27, 2002... 2002 NOV 27 - (NewsRx.com & NewsRx.net) -- The Bush administration is preparing to ask a lame-duck Congress to address one of the stickiest issues in the smallpox vaccine debate: how to compensate people who are injured or killed by the vaccine...

Second vaccine study begins in Oakland, California.(smallpox vaccine)
November 27, 2002... 2002 NOV 27 - (NewsRx.com & NewsRx.net) -- At the Oakland Medical Center, volunteer adults between 32 and 70 years old were revaccinated against smallpox in a study that will test the effectiveness of different dilutions of smallpox vaccine....